Physician

Nicholas David Shokoohi, M.D.

According to 2025 Medicare claims, Nicholas Shokoohi, M.D. (NPI: 1295180214) practices ophthalmology in the Midland, MI market, with the plurality of this provider's patient population coming from Midland, MI. This provider's primary affiliated billing organization is GREAT LAKES EYE INSTITUTE (NPI: 1427090976; TIN: 382334055) and primary practice location at 48603-1334. Shokoohi is affiliated with the POM ACO (ACO ID: A1297), participating under the MSSP model.

Shokoohi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 578 traditional Medicare patients, billed 12,040 HCPCS/CPT codes, and received $720,996 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 1,282 prescription claims across 347 beneficiaries totaling $79,016 in drug costs, led by Brimonidine Tartrate-Timolol (Brimonidine Tartrate/Timolol). Open Payments data shows 10 records totaling $303. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $50,049 to $720,996. Similarly, Part D prescription costs have moved sharply higher in recent years, from $3,661 to $79,016. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$360K$721K2020 Medicare payment: $50,049 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $283,946 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $443,001 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $470,106 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $720,996 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020198490$50,049
20214362,453$283,946
20224963,353$443,001
20235177,165$470,106
202457812,040$720,996

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$40K$79K2017 Drug cost: $3,661 (USD; Tot_Drug_Cst)2018 Drug cost: $11,344 (USD; Tot_Drug_Cst)2019 Drug cost: $18,825 (USD; Tot_Drug_Cst)2020 Drug cost: $17,057 (USD; Tot_Drug_Cst)2021 Drug cost: $36,640 (USD; Tot_Drug_Cst)2022 Drug cost: $51,561 (USD; Tot_Drug_Cst)2023 Drug cost: $67,904 (USD; Tot_Drug_Cst)2024 Drug cost: $79,016 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
20173269$3,661
201850162$11,344
201962269$18,825
202092371$17,057
2021174613$36,640
2022224746$51,561
20232691,037$67,904
20243471,282$79,016

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye169555$83
92014Established patient complete exam of visual system103110$72
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more392817$60
92012Established patient problem focused exam of visual system192376$58
92134Imaging of retina4281,197$27

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol342,197$10,615
Prednisolone AcetatePrednisolone Acetate2427,912$7,912
LatanoprostLatanoprost28017,752$5,846
RhopressaNetarsudil Mesylate12720$5,620
BrinzolamideBrinzolamide12492$2,234

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.10$303Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Nicholas David Shokoohi, M.D.?

Tedicare shows public-source Medicare data for Nicholas David Shokoohi, M.D. (NPI 1295180214), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nicholas David Shokoohi, M.D. have ACO affiliation data?

Nicholas David Shokoohi, M.D. is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297).

What billing organization is linked to Nicholas David Shokoohi, M.D.?

Nicholas David Shokoohi, M.D. is linked to GREAT LAKES EYE INSTITUTE (billing NPI 1427090976) in the available physician profile data.

Does Nicholas David Shokoohi, M.D. have Open Payments data?

Nicholas David Shokoohi, M.D. has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.